Prognostic gene expression profiling (GEP) tests for cutaneous melanoma (CM) are not recommended in current guidelines outside of a clinical trial. However. their use is becoming more prevalent and some practitioners are using GEP tests to guide patient management. Thus. https://www.marcelovicente.com/product-category/restoration-treatment/